As AI and precision medicine redefine drug development, success depends on activating, not just identifying, patients.
“I want my voice heard by the pharmaceutical companies.”
Activating patients alongside Amgen, Bristol Myers Squibb, Pfizer, Lilly, Takeda and Bayer.
Gryt’s differentiator is patient engagement and activation built on trust, not transaction. We enable faster patient activation, more credible insights, and differentiation vs. traditional approaches.
Accelerating recruitment and improving retention by addressing the human barriers AI and data alone cannot solve.
Moving patient insights upstream to inform strategy, research, and education in a more integrated way.
Ensuring the patient voice is authentic, scalable, and defensible to meet regulatory and transparency requirements.
Identifying patients isn’t the challenge. Activating them is. CTPA translates protocols into patient-ready journeys and activates patients through trusted channels.
Explore CTPA →Trusted, authentic patient insights, not just data capture. Advisory boards, patient experience research, and validation of brand strategy and medical education.
See our research →The Patient Voice Council: a cross-stakeholder network advancing patient-centered AI in engagement, recruitment, and retention, with free tools for IRBs and sponsors.
Meet the Council →A global platform uniting patient advocates, caregivers, nonprofit leaders, researchers, and innovators through monthly livestreams and events.
Join the conversation →“Gryt can find the answers to questions we can’t get from traditional EMR approaches.”
“Gryt is an incredible platform to share and learn from our greatest stakeholders: our patients.”
“I think your company’s platform is unique and will undoubtedly improve both the OS and QoL for patients.”
“I want my voice heard by the pharmaceutical companies.”
